Clinical Trial Detail

NCT ID NCT01576172
Title Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

prostate cancer

Therapies

Abiraterone + Prednisone

Abiraterone + Prednisone + Veliparib

Age Groups: adult senior

No variant requirements are available.